Digital transformation of the NHS
Paul Midgley, part of Wilmington Healthcare’s Consulting Team, takes a look at NHSX, the NHS’ new joint organisation for digital, data and technology. NHSX, which...
NICE methods review: APPG report on access to medicines
Claudia Rubin, Director at Decideum, explores a new publication which will inform the National Institute for Health and Care Excellence (NICE) methods review. So many...
Darren Fergus talks why trust matters
Darren Fergus is Managing Director, Sintetica Ltd, discuses a flat hierarchy, shared values and how trust matters to ensure that employees want to stay. When...
Data-driven marketing in pharma: The future is here
Data-driven marketing in pharma, Pamela Walker and Joshua Hull explain why personalisation is the key to unlocking opportunity via pharma digital marketing. In pharma, ‘digital’...
Pharma and biosimilars in the medicines supply chain
Establishing a firmer position for biosimilars in the medicines supply chain represents a huge opportunity for pharma, the NHS and, most importantly, patients. James...
Ensuring best practice in pharma recruitment
Giles Hampson, Managing director at RMG, discusses what should you consider when hiring to ensure best practice in pharma recruitment? Writing as the Managing Director...
Is pharma addressing the gender pay gap?
Reporting on the gender pay gap is now a requirement for companies of a certain size. How is pharma addressing the gender pay gap...
ABPI guidance on patient engagement
A new sourcebook from the ABPI is clearing the way to greater patient engagement within the confines of the Code of Practice. Ambiguity and confusion...
Winning combination for Roche
Pf speaks to Roche’s Pf Awards 2019 winners, Emma Reynolds who won the Secondary Care Specialist Pf Award 2019 and Julie Van Es who...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Latest articles
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Digital interventions for behaviour change
New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Key publications to impact the UK access environment in 2020
Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
Tiofarma admits illegal role in fludrocortisone anti-competitive agreement
Tiofarma has admitted that it took part in a fludrocortisone anti-competitive agreement that resulted in significant price hikes for the essential medicine. This means that...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...